Silverfin false false 30/04/2024 05/04/2023 30/04/2024 Dr B J Vite 05/04/2023 L T Vite 05/04/2023 O T Vite 05/04/2023 12 November 2024 no description of principal activity 14783469 2024-04-30 14783469 bus:Director1 2024-04-30 14783469 bus:Director2 2024-04-30 14783469 bus:Director3 2024-04-30 14783469 core:CurrentFinancialInstruments 2024-04-30 14783469 core:ShareCapital 2024-04-30 14783469 core:RetainedEarningsAccumulatedLosses 2024-04-30 14783469 2023-04-05 2024-04-30 14783469 bus:FilletedAccounts 2023-04-05 2024-04-30 14783469 bus:SmallEntities 2023-04-05 2024-04-30 14783469 bus:AuditExemptWithAccountantsReport 2023-04-05 2024-04-30 14783469 bus:PrivateLimitedCompanyLtd 2023-04-05 2024-04-30 14783469 bus:Director1 2023-04-05 2024-04-30 14783469 bus:Director2 2023-04-05 2024-04-30 14783469 bus:Director3 2023-04-05 2024-04-30 14783469 core:CurrentFinancialInstruments 2023-04-05 2024-04-30 iso4217:GBP xbrli:pure

Company No: 14783469 (England and Wales)

TEE MEDICALS LIMITED

Unaudited Financial Statements
For the financial period from 05 April 2023 to 30 April 2024
Pages for filing with the registrar

TEE MEDICALS LIMITED

Unaudited Financial Statements

For the financial period from 05 April 2023 to 30 April 2024

Contents

TEE MEDICALS LIMITED

STATEMENT OF FINANCIAL POSITION

As at 30 April 2024
TEE MEDICALS LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 April 2024
Note 30.04.2024
£
Current assets
Debtors 3 1,202
Cash at bank and in hand 24,888
26,090
Creditors: amounts falling due within one year 4 ( 11,629)
Net current assets 14,461
Total assets less current liabilities 14,461
Net assets 14,461
Capital and reserves
Called-up share capital 100
Profit and loss account 14,361
Total shareholders' funds 14,461

For the financial period ending 30 April 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Tee Medicals Limited (registered number: 14783469) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

Dr B J Vite
Director

12 November 2024

TEE MEDICALS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 05 April 2023 to 30 April 2024
TEE MEDICALS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 05 April 2023 to 30 April 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Tee Medicals Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 8 The Courtyard Wyncolls Road, Severalls Industrial Park, Colchester, CO4 9PE, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

The company's first accounting period is from incorporation on 5 April 2023 to 30 April 2024.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

Period from
05.04.2023 to
30.04.2024
Number
Monthly average number of persons employed by the Company during the period, including directors 3

3. Debtors

30.04.2024
£
Prepayments and accrued income 1,202

4. Creditors: amounts falling due within one year

30.04.2024
£
Trade creditors 166
Amounts owed to directors 2,797
Accruals 1,680
Corporation tax 6,986
11,629

There are no amounts included above in respect of which any security has been given by the company.